Daré Bioscience, Inc. DARE
0.69 USD +0.01 (+1.78%)
At closeNov 10, 2026, 4:00 PM EST
0.72 +0.02 +3.31%
After hours · Nov 10, 4:00 PM ET
0.6784 Day range 0.71
0.61 52-week range 3.78
- YTD
- -64.14%
- 1 year
- -61.97%
News
globenewswire.com Daré Bioscience to Host Third Quarter 2026 Financial Results and Company Update Conference Call and Webcast on November 16, 2026 SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising…
globenewswire.com Daré Bioscience Releases Next Episode in “CEO Corner” Video Series Sabrina Martucci Johnson, Founder, President and CEO, discusses numerous potential value drivers expected to power the Company's next phase of growth and commercial success
globenewswire.com Daré Bioscience to Present at Stifel's 2026 Healthcare Conference SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares…
benzinga.com Daré Bioscience Receive Additional $1.5M Funding Installment Under Grant Agreement For DARE-LARC1 With this installment, Daré Bioscience has received a total of approximately $43.3 million in non-dilutive funding under the grant agreement. The remaining approximately $5.6 million of the up to…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Biomea Fusion (NASDAQ:BMEA) stock increased by 11.0% to $1.51 during Monday's after-market session. The market value of their outstanding shares is at $102.9 million. iTonic Holdings…